资讯
Cognitive dysfunction has been considered as a morbid condition that may possibly result from aromatase inhibitor therapy, the standard treatment in postmenopausal, estrogen/progesterone receptor ...
[13] Since this 2004 study, aromatase inhibitor use and any effect on cognition remain under consideration. A 2009 ASCO Breast Cancer Symposium review of five studies evaluated the majority of ...
Burnett-Bowie et al. investigated the efficacy and safety of the synthetic aromatase inhibitor anastrozole to treat hypogonadism in aging men. The study enrolled 88 men (60 years or older ...
Early initiation of moderate-intensity aerobic exercise during aromatase inhibitor use reduced pain and prevented pain increases among postmenopausal women with breast cancer. Early initiation of ...
7 个月
SurvivorNet on MSNMajor New Drug Approval For Preventing Recurrence In Early Stage Breast Cancer Patients ...In a long awaited approveall, The Food and Drug Administration (FDA) has just approved the drug Kisqali (ribociclib) in ...
Researchers have found new compounds that could be used to treat a common breast cancer that can be resistant to hormone ...
Considering taking supplements to treat aromatase inhibitor induced arthralgia? Below is a list of common natural remedies used to treat or reduce the symptoms of aromatase inhibitor induced ...
More recently, the ICR Clinical Trials and Statistics Unit, led by Professor Judith Bliss, played an instrumental role in a phase III study of another aromatase inhibitor, exemestane. The results of ...
A recent study published in Scientific Reports investigated iron-doped boron nitride nanoparticles (Fe-BNNPs) as potential nanocarriers for Anastrozole, an aromatase inhibitor used in treating ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果